Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the six research firms that are covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell rating and five have assigned a buy rating to the company. The average 1 year price […]

Shares of Inhibikase Therapeutics, Inc. (NASDAQ:IKT – Get Free Report) have received an average rating of “Buy” from the five research firms that are covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and three have assigned a strong buy recommendation […]